Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.22.1
Condensed Balance Sheets - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Current Assets    
Cash $ 1,598,672 $ 2,020
Prepaid Expense 251,527 35
Other current assets 767,017 0
Total Current Assets 2,617,216 2,055
Other assets 431,357 0
Deferred offering costs 0 429,168
Investments held in the Trust Account 235,771,456 0
Total Assets 238,820,029 431,223
Current Liabilities:    
Accounts payable and accrued expenses 17,322 5,975
Accrued offering costs 0 305,000
Advances from related party 0 101,326
Note payable - Sponsor 0 86,000
Total Current Liabilities 17,322 498,301
Other long-term liabilities 1,506,000 0
Deferred underwriting commission 6,900,000 0
Total Liabilities 8,423,322 498,301
COMMITMENTS AND CONTINGENCIES (Note 6)
Class A common stock subject to possible redemption; 23,000,000 and no shares outstanding as of March 31, 2022 and December 31, 2021, respectively (at $10.25 per share) 235,750,000 0
Stockholders' deficit:    
Preferred shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding 0 0
Additional paid-in capital 0 24,425
Accumulated deficit (5,353,868) (92,078)
Total Stockholders' Deficit (5,353,293) (67,078)
Total Liabilities, Common Stock subject to Possible Redemption and Stockholders' Deficit 238,820,029 431,223
Common Class A [Member]    
Stockholders' deficit:    
Common Stock, Value, Issued 0 0
Common Class B [Member]    
Stockholders' deficit:    
Common Stock, Value, Issued $ 575 $ 575